| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.18 | 4e-05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.43 | 0.01 |